Reference : Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell trans...
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/9455
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.
English
Baron, Frédéric mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
Baudoux, Etienne mailto [Centre Hospitalier Universitaire de Liège - CHU > > Thérapie cellulaire >]
Fillet, Georges mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
Beguin, Yves mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
2002
Hematology
Taylor & Francis
7
3
137-43
Yes (verified by ORBi)
International
1024-5332
1607-8454
London
United Kingdom
[en] Adolescent ; Adult ; Antigens, CD34 ; Antigens, CD8 ; Bone Marrow Transplantation ; Feasibility Studies ; Female ; Graft Survival ; Graft vs Host Disease ; Humans ; Lymphocyte Depletion ; Lymphocyte Transfusion/methods ; Male ; Middle Aged ; Peripheral Blood Stem Cell Transplantation/adverse effects/methods/mortality ; Retrospective Studies ; Survival Analysis ; Transplantation, Homologous ; Treatment Outcome
[en] We have previously reported the feasibility of allogeneic CD34-selected PBSC transplantation followed by pre-emptive CD8-depleted DLI (study group). In this report, we retrospectively compare the clinical outcome of the 24 patients included in this study with an historical group of 35 patients receiving unmanipulated marrow (BMT group). Patients in the study group had significantly faster neutrophil and platelet recovery and were discharged earlier than BMT patients. The actuarial 150-day (after DLI) probability of developing grade II-IV acute GVHD was 28% for the study group versus 62% for the BMT group (p=0.002). The actuarial 2-year probability of developing chronic GVHD was similar (37 versus 36% (NS)) but chronic GVHD was significantly delayed in the study group (p=0.003). The actuarial 2-year probability of relapse was 30% in the study group versus 33% in the BMT group (NS). The actuarial 2-year probability of survival was 45% in the study group versus 43% in the BMT group (NS). We conclude that allogeneic transplantation of CD34-selected PBSC followed by pre-emptive CD8-depleted DLI is feasible with rapid engraftment and minimizes the risk of severe GVHD. Large prospective trials are required to confirm these results.
http://hdl.handle.net/2268/9455
10.1080/1024533021000008173

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
165-Author.pdfPublisher postprint92.21 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.